World-Class Cardiac Arrhythmia Management
Confronting the burden of cardiac arrhythmias
The global burden of cardiac arrhythmias is staggering. Patients with atrial tachycardias (ATs) and atrial fibrillation (AF) face an increased risk for stroke, dementia, heart failure and death,1 and the number of patients with AF is expected to double in the next 40 years.2 Ventricular tachycardia (VT) and ventricular fibrillation (VF) are even more serious. Sustained VT is fatal. Analysts estimate that annually almost 4 million people experience sudden cardiac death worldwide, with about half of those deaths attributed to VT,3 including approximately 300,000 in the United States.4
Arrhythmia management is multifaceted, requiring creative solutions that span the patient care continuum–from insight to therapy. Our arrhythmia management portfolios give you the options you need to precisely diagnose, treat and manage arrhythmias with versatility and efficacy. When it comes to understanding and managing cardiac arrhythmias, we are your partner for life.